Company
Headquarters: Beijing, China
Employees: 503
CN¥17.44 Billion
CNY as of Jan. 1, 2025
US$2.39 Billion
Company | Market Cap (USD) |
---|---|
Intuitive | $216.79 B |
EssilorLuxottica SA | $116.96 B |
Becton, Dickinson and Company | $69.74 B |
HOYA Corp | $45.26 B |
Alcon Inc. | $41.55 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Eye Bright Medical Technology Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases. The company was founded in 2010 and is based in Beijing, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | CN¥1.36 B |
EBITDA | CN¥447.2 M |
Gross Profit TTM | CN¥722.9 M |
Profit Margin | 27.21% |
Operating Margin | 33.14% |
Quarterly Revenue Growth | 49.10% |
Eyebright Medical Technology has the following listings and related stock indices.
Stock: SSE: 688050 wb_incandescent